Cargando…
Comparison of Generic Prescribing Patterns Among 340B-Eligible and Non-340B Prescribers in the Medicare Part D Program
This cross-sectional study examines generic prescribing patterns for 2020 among 340B-eligible and non-340B clinicians in the Medicare Part D program to assess whether 340B revenue incentives may influence prescribing.
Autores principales: | Dickson, Sean, James, Katelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199350/ https://www.ncbi.nlm.nih.gov/pubmed/37204805 http://dx.doi.org/10.1001/jamahealthforum.2023.1026 |
Ejemplares similares
-
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023) -
Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals
por: Li, Yufei, et al.
Publicado: (2022) -
The 340B Program and Health Disparities Among Medicare Beneficiaries
With Chronic Asthma
por: Tripp, Amanda S, et al.
Publicado: (2023) -
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016
por: Conti, Rena M., et al.
Publicado: (2019) -
Outcomes of the 340B Drug Pricing Program: A Scoping Review
por: Knox, Ryan P., et al.
Publicado: (2023)